| Wed, Jul 8, 2009 | | • | CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Jul 8)
| | Wed, Jul 1, 2009 | | • | FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
at Seeking Alpha (Wed, Jul 1)
| | Tue, Jun 30, 2009 | | • | CytRx files FDA report on halted clinical trial
at MarketWatch (Tue, Jun 30)
| | • | CytRx Files Report with the FDA in Response to the Partial Clinical Hold on its Phase 2b Arimoclomol ALS Trial
Business Wire (Tue, Jun 30)
| | Mon, Jun 29, 2009 | | • | CytRx Reports Favorable Progress Update for Its Pivotal Phase 2 Clinical Trial with Tamibarotene as a Third-line Treatment for Acute Promyelocytic Leukemia
Business Wire (Mon, Jun 29)
| | Thu, Jun 25, 2009 | | • | Closing Update for June 25
at Seeking Alpha (Thu, Jun 25)
| | • | CytRx to Present Statistically Significant Evidence of Arimoclomol's Ability to Protect Experimental Animals from the Effects of Hypoxia at the 2009 International Society on Oxygen Transport to Tissue Conference
Business Wire (Thu, Jun 25)
| | Wed, Jun 17, 2009 | | • | CytRx's Tamibarotene Demonstrates Statistically Significant Anti-Tumor Activity in Animal Trial for Multiple Myeloma
Business Wire (Wed, Jun 17)
| | Mon, Jun 8, 2009 | | • | [$$] Biotech and China Still Have Aggressive Trading
at RealMoney by TheStreet.com (Mon, Jun 8)
| | • | Movers roundup: Massey Energy, MannKind
AP (Mon, Jun 8)
| | • | CytRx rises on analyst's 'Outperform' rating
AP (Mon, Jun 8)
| | • | Coverage initiated on CytRx by Rodman & Renshaw
Briefing.com (Mon, Jun 8)
| | Tue, May 19, 2009 | | • | CYTRX CORP Financials
EDGAR Online Financials (Tue, May 19)
| | Tue, May 12, 2009 | | • | CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Tue, May 12)
| | • | CytRx Reports 2009 First Quarter Financial Results
Business Wire (Tue, May 12)
| | Mon, May 11, 2009 | | • | CYTRX CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 11)
| | Tue, May 5, 2009 | | • | Ex-Facet Biotech business development chief hired away
at bizjournals.com (Tue, May 5)
| | • | CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, May 5)
| | • | CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Business Wire (Tue, May 5)
| | Fri, Mar 13, 2009 | | • | CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Mar 13)
|
Add CYTR News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
